Sally C. Pipes
Commentary
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Commentary
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Commentary
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...
Commentary
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
340B. drug pricing
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Commentary
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
Commentary
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
Commentary
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Commentary
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Commentary
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
Learn more about health care reform
What Trump’s health care plan could look like
Former President Donald Trump has been jeered for saying he has “concepts of a plan” for repealing and replacing Obamacare. But that’s not quite fair. Trump’s first term in office suggests that he favors market-based reforms that increase patients’ choices. With just under a month until the election, it’s time ...
Learn more about how price fixing stifles innovation
New Schizophrenia Drug Represents Promise Of Pharmaceutical Innovation
Late last month, the U.S. Food and Drug Administration approved Bristol Myers Squibb’s KarXT, a treatment for schizophrenia. The drug, which will be marketed under the brand name Cobenfy, is promising not just because it is effective at treating the debilitating mental health condition. It also seems not to have the potentially harmful side ...
Learn more about healthcare reform
Vance’s Critics Wrong: No Need to Fear High-Risk Pools
Following the recent vice-presidential debate, Sen. J.D. Vance, R-Ohio, continues to face attacks on his ideas for covering people with pre-existing conditions. Vance’s critics call his proposal — which would separate out sicker patients into a separate high-risk insurance pool — inhumane and impractical. As Arthur Caplan, the head of medical ethics at NYU ...
Learn how Vance's suggestion would benefit consumers
Vance’s Argument on Preexisting Conditions a Sure Winner
When asked how people with pre-existing conditions would fare under a Trump-Vance administration during last week’s vice-presidential debate, Sen. J.D. Vance, R-Ohio, was unequivocal. “Well, of course, we’re going to cover Americans with pre-existing conditions.” The question was prompted by Vance’s statement last month that the Republican ticket would consider creating different risk ...
How The Hospital Industrial Complex Robs Poor Patients
Pharmaceutical leader Johnson & Johnson recently unleashed a firestorm in Washington after it proposed a change to how it offers discounted prices on two drugs in a little-known, but enormous, federal program that’s hurting the low-income patients it was created to help. That program, known as the “340B Drug Pricing Program,” allows ...
Harris’s Farcical Price Control Schemes
Karl Marx famously said that history repeats itself first as tragedy, then as farce. Vice President Kamala Harris is bringing that aphorism to life by putting price controls at the center of her economic agenda. Despite centuries of evidence that such controls invariably lead to shortages, rationing and general economic ...
American Healthcare Broken? Says Who?
A new study from the Commonwealth Fund ranks the U.S. health system dead last among 10 developed nations. But is healthcare in the United States really that bad? A close look at the data suggests otherwise. Read the full article in Newsmax.
A British Lord’s Warning: Steer Clear of Single-Payer Healthcare
Two hundred and fifty years ago, a group of Americans sounded the alarm about the oppressive government policies being propagated by British lords. Today, the tables have turned. This month, Lord Ara Darzi presented the United Kingdom’s Secretary of State for Health and Social Care with a devastating report on the state ...
Women, Children, Disabled Pay The Price For Obamacare’s Medicaid Expansion
Obamacare greatly expanded Medicaid eligibility. As a result, about 20 million able-bodied, working-age adults who were previously ineligible are now enrolled in the program. But as a new report from the Paragon Health Institute makes clear, their gains have come at the expense of the pregnant women, children, and people ...
Learn how PBMs pocket savings intended for patients
How Long Can Pharmacy Benefit Managers Go Unchecked?
Last week, a House subcommittee held a hearing on pharmacy benefit managers and their impact on the prices patients pay for prescription drugs. The hearing speaks to voters’ concerns. Republicans and Democrats alike have identified the cost of prescription drugs as their No. 2 health care concern, according to polling ...
